US Broker Ratings

Insulet Corporation (PODD) Stock Analysis: Riding High on a 13.84% Potential Upside

Insulet Corporation (NASDAQ: PODD) continues to be a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $22.43..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a key player in the healthcare sector, particularly within the medical devices industry. With a substantial market capitalization..

UnitedHealth Group (UNH) Stock Analysis: Healthcare Giant with a 4.33% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, boasting a market capitalization of $322.96 billion. This sprawling healthcare titan operates..

Masimo Corporation (MASI) Stock Analysis: Exploring a 27.79% Potential Upside

Investors with an eye on the healthcare sector may want to consider Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices industry. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Examining a 12.77% Potential Upside in Biotechnology

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector with a market capitalization of $10.57 billion, reflecting its established presence in the healthcare industry. Specializing..

Veeva Systems Inc. (VEEV) Stock Analysis: Assessing Growth Potential with a 13% Upside

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, is capturing investor interest with a potential upside of 13%,..

Incyte Corporation (INCY): Investor Outlook on Growth and Market Position

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents an intriguing case for investors focused on the healthcare industry. With a market capitalization..

Elanco Animal Health (ELAN) Investor Outlook: Navigating Growth in the Animal Health Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing the 16% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a key player in the biotechnology sector, has been capturing attention with its promising clinical-stage developments. Based in the United Kingdom,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 26.49% Upside Potential Awaits Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, specializes in designing and manufacturing single-use medical products. The company, which operates through..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Robust Healthcare Giant with a Marginal Potential Upside

HCA Healthcare, Inc. (NYSE: HCA) stands as a behemoth in the healthcare sector, boasting a formidable market capitalization of $99.72 billion. Headquartered in Nashville, Tennessee, HCA..

BeOne Medicines Ltd. (ONC) Investor Outlook: Key Insights on a 20.86% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its robust pipeline of oncology treatments. Headquartered..

Novo Nordisk A/S (NVO): Investor Outlook with 16% Upside Potential Amid Strong Revenue Growth

Novo Nordisk A/S (NYSE: NVO) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Bagsvaerd, Denmark, the company..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring the 12.55% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, presents a compelling investment opportunity with a potential upside of 12.55%. With a diverse..

Exact Sciences Corporation (EXAS) Stock Analysis: A 12.95% Upside with Strong Buy Ratings

Exact Sciences Corporation (NASDAQ: EXAS) is drawing significant attention from investors, especially in the healthcare sector, with its promising diagnostic and screening products for cancer detection...

CVS Health Corporation (CVS): Investor Outlook and Growth Potential Amidst Healthcare Sector Dynamics

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, is drawing investor attention with its robust market presence and diversified service offerings. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: Unpacking a 27% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NUVL), a dynamic player in the biotechnology industry, has been making waves with its promising pipeline in the cancer treatment domain. With a market..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating High Growth and Strategic Collaborations in Healthcare Tech

In the rapidly evolving landscape of healthcare technology, Tempus AI, Inc. (NASDAQ: TEM) is carving a niche with its robust suite of data-driven solutions and strategic..

Medpace Holdings, Inc. (MEDP) Stock Analysis: An Insight into Growth and Valuation Amidst Mixed Analyst Ratings

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unpacking a 21% Upside Potential Amidst Solid Revenue Growth

Investors with an eye on the healthcare sector might find Neurocrine Biosciences, Inc. (NASDAQ: NBIX) particularly compelling, given its promising 21.12% upside potential. This San Diego-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds